Company chart and information is provided by TradingView based on 15-minute-delayed data.
BiondVax is a publicly traded, innovative biopharmaceutical company developing a Universal Flu Vaccine, providing multi-season and multi-strain protection against all human influenza virus strains, both seasonal and pandemic.
Website: | www.biondvax.com |
Main Phone: | +972 89302529 |
Address: | Hadassah Ein Kerem Campus |
Address 2: | Jerusalem BioPark, 2nd floor |
City / Town: | Jerusalem |
Country: | IL |
Postal Code: | 74036 |
Exchange: | NSC |
CEO: | Ron Babecoff |
Employees: | 25 |
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |